Shepherd Kaplan Krochuk’s Novartis NVS Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,678	Closed	-$236K	–	434
2015 Q2	$236K	Hold	2,678	–	–	0.04%	271
2015 Q1	$237K	Sell	2,678 -1,295	-33%	-$115K	0.04%	265
2014 Q4	$330K	Hold	3,973	–	–	0.05%	267
2014 Q3	$335K	Buy	3,973 +625	+19%	+$50.6K	0.04%	280
2014 Q2	$272K	Hold	3,348	–	–	0.03%	387
2014 Q1	$255K	Hold	3,348	–	–	0.03%	391
2013 Q4	$241K	Hold	3,348	–	–	0.03%	385
2013 Q3	$230K	Hold	3,348	–	–	0.04%	406
2013 Q2	$212K	Buy	+3,348	New	+$218K	0.04%	416

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Shepherd Kaplan Krochuk's NVS Position: Q3 2015 in Review

Shepherd Kaplan Krochuk sold out of Novartis (NVS) in Q3 2015, closing a stake of 2,678 shares — an estimated $236K sold.

Shepherd Kaplan Krochuk first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $335K in Q3 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Shepherd Kaplan Krochuk reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 2,678 Novartis shares in Q3 2015, an estimated $236K.
Shepherd Kaplan Krochuk first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
Shepherd Kaplan Krochuk's Novartis position peaked at $335K in Q3 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q3 2015, filed 16 Nov 2015.